Exponent, Inc. (NASDAQ:EXPO) is considered one of the 15 Overlooked Dividend Stocks to Buy Right Now. Truist maintained a Buy rating on EXPO but lowered the price target to $90, citing potential risks from automation. In Q3 2025, EXPO reported a 10% increase in revenue before reimbursements to $137.1 million. The company specializes in engineering and scientific consulting, delivering solutions for complex technical challenges. While EXPO shows promise as an investment, some AI stocks may offer greater potential. Consider exploring opportunities in AI stocks for significant upside.

Read more at Yahoo Finance: Truist Maintains Buy Rating on Exponent (EXPO) While Cutting Price Target to $90